LSE:NCYT (Novacyt S.A.)

About NCYT

Novacyt SA is engaged in developing and selling diagnostic products for cancer and infectious diseases. Its diagnostic products are used in LBC, oncology, microbiology, hematology, and serology testing. The company operates its business through the following business segments. Primerdesign is the designer, manufacturer, and marketer of molecular 'real-time' qPCR testing devices and reagents in the areas of infectious diseases based in Southampton, UK: Lab21 Product segment is a developer, manufacturer, and distributor of a large range of protein-based infectious disease IVD products; IT-IS International segment develops PCR devices for the life sciences and food testing industry and Corporate segment.
  • Novacyt S.A. (LSE: NCYT) Latest News

    Investing Articles

    The Novacyt share price just slumped! Here’s why?

    The Novacyt share price dropped on Tuesday morning after the firm updated shareholders on a dispute with the UK government.

    Read more »

    Investing Articles

    Is the Novacyt (LON:NCYT) share price now a screaming buy?

    The Novacyt share price boomed on the back of demand for its Covid test kits. But that bubble has burst,…

    Read more »

    Investing Articles

    The Novacyt share price is down 77% in a year – is it now a glaring buy?

    After the company's successful roll out of Covid testing kits, is the Novacyt share price now attractive for a long-term…

    Read more »

    Investing Articles

    The Novacyt (LON:NCYT) share price continues to tumble on delays

    The Novacyt (LON:NCYT) share price continues to decline after pandemic disruptions cause a six-month delay in new product launches.

    Read more »

    Investing Articles

    Is this why the Novacyt share price keeps falling?

    Rupert Hargreaves explains why the Novacyt share price is sliding and could remain under pressure as the company's profits fall.

    Read more »

    Investing Articles

    What’s going on with the Novacyt (NCYT) share price?

    After months of decline, the Novacyt (NCYT) share price started rising last month. Is this a sign to buy? Zaven…

    Read more »

    Investing Articles

    3 dirt-cheap AIM stocks. Should I buy?

    Paul Summers picks out three lowly-valued AIM stocks that could turn out to be huge bargains in time. But are…

    Read more »

    Syringe and vial on blue background
    Investing Articles

    The Novacyt (NCYT) share price: is it set to soar again?

    The Novacyt share price (LON: NCYT) collapsed earlier in 2021. But the latest news has sent it heading upwards again.…

    Read more »

    Investing Articles

    Is the Novacyt (NCYT) share price about to bounce back?

    The Novacyt share price is rising today. Is the worst over for shareholders, or do risks remain? Roland Head looks…

    Read more »

    Investing Articles

    Should I buy Novacyt shares at under 400p?

    The Novacyt share price is rising today, but 45% of the company's 2020 sales are under dispute. Can the company…

    Read more »

    Woman sneaker shoe and Arrow on street with copy space background
    Investing Articles

    Can the Novacyt (NCYT) share price make a comeback?

    The Novacyt (NCYT) share price has had a rough year, falling by nearly 60% since January. But is it about…

    Read more »

    Investing Articles

    What’s happening to the Novacyt share price?

    The Novacyt share price surged 6,000% in 2020. But this year, the stock has plummeted. Zaven Boyrazian investigates what’s happened.

    Read more »